Joseph H. Antin, MD, Dana-Farber Cancer Institute
Advertisement
Articles by Joseph H. Antin, MD, Dana-Farber Cancer Institute
Advertisement
Latest Updated Articles
Risk Factors for Graft-vs-Host DiseaseJune 19th 2020
Special Transplant SituationsJune 19th 2020
Members of the Transplant TeamJune 19th 2020
Timing of Referral for TransplantJune 19th 2020
Graft-vs-Host Disease Prophylaxis Clinical TrialsJune 19th 2020
Advertisement
Advertisement
Trending on OncLive
1
Managing Long-Term Toxicities and Emerging Therapies in ALK-Positive NSCLC
2
Five Under 5: Top Oncology Videos for the Week of 6/28
3
The OncFive: Top Oncology Articles for the Week of 6/28
4
Divesiran Reduces Phlebotomy Burden and Improves Iron Stores in Polycythemia Vera
5